Medtronic plc (MDT) said Friday it received approval from the U.S. Food and Drug Administration or FDA for the DiamondTemp Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.
According to Medtronic, the DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency or RF ablation system with diamonds currently available to deliver ablations.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.